Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

ACHV Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 15, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Achieve Life Sciences Inc (ACHV)

Based on 13 analysts giving stock ratings to Achieve Life Sciences Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
15
Buy
77
Hold
8
Sell
0
Strong Sell
0
Achieve Life Sciences Inc

Achieve Life Sciences Inc. Stock Analysis ACHV

United States Health Care Small Cap Report:
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. The company is headquartered in Seattle, Washington and currently employs 28 full-time employees. The firm focuses on addressing the global smoking health and nicotine dependence epidemic through the development and commercialization of cytisinicline. The company has completed two Phase III studies with cytisinicline for smoking cessation and one Phase II study with cytisinicline in vaping cessation. Cytisinicline is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a dual-acting mechanism of action, being both a receptor agonist and antagonist. Cytisinicline is an investigational product candidate being developed for the treatment of nicotine dependence and has not been approved by the Food and Drug Administration for any indication in the United States. Cytisinicline acts as a partial agonist/antagonist, binding to alpha-4 beta-2 nicotinic receptors in the brain and is thought to have two potential consequences in treating nicotine dependence.
Read More

Achieve Life Sciences Inc (ACHV) Chart

Key Statistics of Achieve Life Sciences Inc (ACHV)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$4.86$5.16

Today's Open

$4.98

Volume

2.12M

P/E Ratio (TTM)

-

52 Week Range

$2.00$6.16

Market Cap

472.23M

Avg. Volume

1.85M

Dividend Yield

-

Financial Metrics & Statements of Achieve Life Sciences Inc (ACHV)

FAQ's for Achieve Life Sciences Inc (ACHV)

  • According to Musaffa’s Shariah screening methodology, Achieve Life Sciences Inc (ACHV) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Achieve Life Sciences Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Achieve Life Sciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Achieve Life Sciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Achieve Life Sciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Achieve Life Sciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.